American Journal of Psychiatry

Article	Citations
Broadening the Parameters of Clinical High Risk for Psychosis	504
2024 Annual Meeting: Presidential Address	218
Genes To Mental Health (G2MH): A Framework to Map the Combined Effects of Rare and Common Variants on Dimensions of Cognition and Psychopathology	151
Evaluating Associations Between Cannabis and Heroin Use	142
Treating Pathologies of the Will	134
Integrating Clinical and Basic Research: Opioid Use Disorder, Psychotic Illnesses, and Prefrontal Microcircuits Relevant to Schizophrenia	125
Mental Health Disparities Research: An Introduction to New Directions	120
Highlights From the Residents’ Journal: December 2021	117
Brain-Based Biotypes of Psychiatric Vulnerability in the Acute Aftermath of Trauma	116
Effectiveness of Antipsychotic Use for Reducing Risk of Work Disability: Results From a Within-Subject Analysis of a Swedish National Cohort of 21,551 Patients With First-Episode Nonaffective Psychosi	107
20-Year Prospective, Sequential Follow-Up Study of Heterogeneity in Associations of Duration of Untreated Psychosis With Symptoms, Functioning, and Quality of Life Following First-Episode Psychosis	99
Future of Sensorimotor and Psychomotor Dysfunction in Mental Disorders: Emerging Tools, Methodological Challenges, and the Road Ahead	99
Predicting Conversion to Psychosis: What Lies Beyond the Biomarkers?	97
A New Agenda for Optimizing Investments in Community Mental Health and Reducing Disparities	94
A Call to Psychiatrists: Deprescription of Unnecessary Anticholinergic Medications in Schizophrenia Must Start Now	94
Intentional Drug Overdose Deaths in the United States	94
Neural Signatures of Pain Modulation in Short-Term and Long-Term Mindfulness Training: A Randomized Active-Control Trial	91
Cannabis and Brain Health: What Is Next for Developmental Cohort Studies?	88
From Scanner to Bedside: Building Bridges in Translational Psychiatric Neuroimaging	88
Can Neuromelanin-Sensitive MRI Provide Insight Into the Dopaminergic Pathways Contributing to Substance Use?	85
Depression, Inflammation, and Postpartum Psychosis	84
From Prediction to Action: Moving Beyond Machine Learning to Implementing Evidence-Based Perinatal Mental Health Care	83
Project Harmony: A Meta-Analysis With Individual Patient Data on Behavioral and Pharmacologic Trials for Comorbid Posttraumatic Stress and Alcohol or Other Drug Use Disorders	82
On the Genetic and Environmental Relationship Between Suicide Attempt and Death by Suicide	79
New Insights Into Psychotic Disorders	75

Trends in Prescription Stimulant, Opioid, and Benzodiazepine Use and Diversion in U.S. Adolescents	74
Reduced Brain Responsiveness to Emotional Stimuli With Escitalopram But Not Psilocybin Therapy for Depression	73
An Innovative Approach to Extending the Antidepressant Effects of Intravenous Ketamine in Major Depression	70
Durability of Effects of Cognitive Remediation on Cognition and Psychosocial Functioning in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials	70
2024 Annual Meeting: CEO and Medical Director’s Address	67
Highlights From the Residents’ Journal: September 2021	67
Correcting Overestimations in Self-Harm Visit Data	65
APA Council Reports	62
Highlights From the Residents’ Journal: September 2024	61
Coordinate Network Mapping: An Emerging Approach for Morphometric Meta-Analysis	59
Corrigendum to Morley et al.	59
Older Adults are at Heightened Risk of the Effects of Cannabis Use: Response to Walaszek	59
Correction to Poirot et al.	59
Methamphetamine-Induced Psychosis and Schizophrenia: A Call for Special Attention: Response to Zhu et al.	58
Suicide and the Menstrual Cycle	56
The First Large GWAS Meta-Analysis for Postpartum Depression	54
Sensitivity of Schizophrenia Endophenotype Biomarkers to Anticholinergic Medication Burden	53
Familial Risk of Postpartum Psychosis	53
Schizophrenia Imaging Signatures and Their Associations With Cognition, Psychopathology, and Genetics in the General Population	53
Characterizing the Most Vulnerable Prefrontal Cortical Neurons in Schizophrenia	52
Back to the Future: Esmethadone, the (Maybe) Nonopiate Opiate, and Depression	51
Early Adversity and Development: Parsing Heterogeneity and Identifying Pathways of Risk and Resilience	51
Neural Responses to Intranasal Oxytocin in Youths With Severe Irritability	51
12-month Prevalence Estimates of Substance Use Disorders Using DSM-5 Versus DSM-IV Criteria Among U.S. Nonelderly Adults With Substance Use	51
Similar Rates of Deleterious Copy Number Variants in Early-Onset Psychosis and Autism Spectrum Disorder	48
Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial	48
Points that Need Attention in Early Auditory Information Processing Research in Schizophrenia: Response to Lin and Hsieh	47
Sexual Identity Continuity and Change in a U.S. National Probability Sample of Sexual Minority Adults: Associations With Mental Health and Problematic Substance Use	47
Proof-of-Principle Study on ECT Illustrates Challenges and Possible Merits of Using Polygenic Risk Scores to Predict Treatment Response in Psychiatry	47
Rebecca W. Brendel, M.D., J.D., 149th President, 2022–2023	46
Comment on “Elevated C-Reactive Protein in Patients With Depression, Independent of Genetic, Health, and Psychosocial Factors: Results From the UK Biobank”	45
Scientific Advances Relevant to Schizophrenia, Psychosis, and the Treatment of Methamphetamine Use Disorder	45
From Crisis to Action: Psychiatry’s Ethical Imperative to Defend Transgender People’s Rights, Dignity, and Access to Care	45
The Safety of Pimavanserin for Parkinson’s Disease and Efforts to Reduce Antipsychotics for People With Dementia	45
Risk of Incident Psychosis and Mania With Prescription Amphetamines	44
Sustained Efficacy of Stanford Neuromodulation Therapy (SNT) in Open-Label Repeated Treatment	43
Genetic and Environmental Contribution to the Co-Occurrence of Endocrine-Metabolic Disorders and Depression: A Nationwide Swedish Study of Siblings	43
Predictive Value of Acute Neuroplastic Response to rTMS in Treatment Outcome in Depression: A Concurrent TMS-fMRI Trial	42
Associations Between a Primary Care-Delivered Alcohol-Related Brief Intervention and Subsequent Opioid-Related Outcomes	42
Aberrant Developmental Patterns of Gamma-Band Response and Long-Range Communication Disruption in Youths With 22q11.2 Deletion Syndrome	40
The Neglected Role of Psychotherapy for Treatment-Resistant Depression	39
Shared and Specific Neural Correlates of Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder: A Meta-Analysis of 243 Task-Based Functional MRI Studies	39
Alcohol and the Etiology of Depression	39
Ketamine for Depression, but at What Cost? A Review of Ketamine’s Neurotoxic Effects From Preclinical and Human Studies	38
Suicide in Black Females	36
2021 Articles of Import and Impact	36
Risk of Experiencing an Overdose Event for Patients Undergoing Treatment With Medication for Opioid Use Disorder	35
Slowly Working Toward More Treatments for Depression in Bipolar II Disorder	35
What Do Four Decades of Research Tell Us About the Association Between Childhood Adversity and Psychosis: An Updated and Extended Multi-Level Meta-Analysis	35
Synaptic Variability and Cortical Gamma Oscillation Power in Schizophrenia	35

Psychotherapy in Psychedelic Treatment: Safe, Evidence-Based, and Necessary	34
Psilocybin: From Psychiatric Pariah to Perceived Panacea	34
Reduction in Trauma-Related Symptoms After Anesthetic-Induced Intra-Operative Dreaming	34
Neuromodulation Strategies for the Treatment of Depression	33
Double-Blind, Sham-Controlled Randomized Trial Testing the Efficacy of fMRI Neurofeedback on Clinical and Cognitive Measures in Children With ADHD	33
Neural Correlates of Stress and Alcohol Cue-Induced Alcohol Craving and of Future Heavy Drinking: Evidence of Sex Differences	33
Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression	33
The American Psychiatric Association Practice Guideline for the Treatment of Patients With Eating Disorders	32
Predicting Acute Changes in Suicidal Ideation and Planning: A Longitudinal Study of Symptom Mediators and the Role of the Menstrual Cycle in Female Psychiatric Outpatients With Suicidality	32
Treatment Response Prediction in Major Depressive Disorder Using Multimodal MRI and Clinical Data: Secondary Analysis of a Randomized Clinical Trial	32
Diagnosing Prescription Opioid Use Disorder in Patients Using Prescribed Opioids for Chronic Pain	31
Can Smartphone-Based Support Apps Add Value to the Treatment of Opioid Use Disorder?	30
The Association of Childhood Maltreatment and Mental Health Problems: Partly Causal and Partly Due to Other Factors	30
When Will There Be Good News?	30
Correction to Baum et al.	30
Keeping Track and Providing Tools for Future Crisis Management: Suicide Attempt and Self-Harm Presentations at Emergency Departments	30
Drug Cues Trigger Corticolimbic Hyperreactivity in Heroin Users	30
Toward Precision Noninvasive Brain Stimulation	30
Setting the Record Straight on Long-Term Use, Dose Escalation, and Potential Misuse of Prescription Benzodiazepines	29
Differences in Social Determinants of Health Underlie Racial/Ethnic Disparities in Psychological Health and Well-Being: Study of 11,143 Older Adults	29
Racial and Ethnic Biases and Psychiatric Misdiagnoses: Toward More Equitable Diagnosis and Treatment	29
Psychological Support for Psilocybin Treatment: Reply to Letters on Our Commentary	29
Innovative Directions to Advance Mental Health Disparities Research	29
Beneath the Phenotypic Surface: Pleiotropy Shapes the Co-Occurrence of Alcohol Use Disorder and Psychopathology	29
Interindividual Differences in Cortical Thickness and Their Genomic Underpinnings in Autism Spectrum Disorder	28
Mortality Among Parkinson’s Disease Patients Treated With Pimavanserin or Atypical Antipsychotics: An Observational Study in Medicare Beneficiaries	28
Harnessing the Power of Population Cohorts to Study the Relationship Between Endocrine-Metabolic Disorders and Depression	28
Psychiatric Diagnoses in Parents and Psychiatric, Behavioral, and Psychosocial Outcomes in Their Offspring: A Swedish Population-Based Register Study	28
A Case of Prolonged Mania, Psychosis, and Severe Depression After Psilocybin Use: Implications of Increased Psychedelic Drug Availability	28
Evaluating the Evidence for Brain-Based Biotypes of Psychiatric Vulnerability in the Acute Aftermath of Trauma	27
A Novel, Brief, Fully Automated Intervention to Extend the Antidepressant Effect of a Single Ketamine Infusion: A Randomized Clinical Trial	26
The Amygdala and Depression: A Sober Reconsideration	26
Auditory Steady-State Responses Probe GABA-Related Oscillatory Cortical Circuits and Their Relation to Neurodevelopmental Mental Disorders	26
2024 Articles of Import and Impact	25
Correction	25
Ketamine After Two Antidepressants?	25
Guilt by Association: Inflammation and Shared Genetic Risk Between Stress-Related and Immune Disorders	25
Neuromelanin-Sensitive MRI: A Biomarker for Treatment-Resistant Schizophrenia?	24
Recommendations for the Usage of Ketamine and Esketamine	24
Understanding the Effects of Combined Lisdexamfetamine and Cognitive Behavior Therapy for Adults With Binge Eating Disorder	24
Highlights From the Residents’ Journal: December 2024	24
Progress and Challenges in GxE Research on Depression	24
Functional Connectivity Mapping for rTMS Target Selection in Depression	23
Associations Between General and Specific Mental Health Conditions in Young Adulthood and Cardiometabolic Complications in Middle Adulthood: A 40-Year Longitudinal Familial Coaggregation Study of 672,	23
Drugs and Addiction Science: NIDA Celebrates 50 Years of Research and Looks to the Future	23
Ketamine and Esketamine for Treatment-Resistant Depression: Response to Reus, Mattes, and Schatzberg	23
Meta-Analyses of Genome-Wide Association Studies for Postpartum Depression	23
REL-1017 (Esmethadone) as Adjunctive Treatment in Patients With Major Depressive Disorder: A Phase 2a Randomized Double-Blind Trial	23
Longitudinal Trajectory of the Link Between Ventral Striatum and Depression in Adolescence	23
Current and Future Approaches to Pediatric Anxiety Disorder Treatment	22
Technology and Mental Health: State of the Art for Assessment and Treatment	22
Cannabis Use and the Endocannabinoid System: A Clinical Perspective	22
Converging Evidence for Frontopolar Cortex as a Target for Neuromodulation in Addiction Treatment	21
Shared and Unique Changes in Brain Connectivity Among Depressed Patients After Remission With Pharmacotherapy Versus Psychotherapy	21
Rethinking the First Episode of Schizophrenia: Identifying Convergent Mechanisms During Development and Moving Toward Prediction	20
Can Two 90-Minute Workshops Reduce Risk of Substance Use Disorder for Vulnerable Seventh Graders? Results and Scalability From the Co-Venture Trial	20
Auditory Oddball Responses Across the Schizophrenia-Bipolar Spectrum and Their Relationship to Cognitive and Clinical Features	20
Vaccines as Immunotherapies for Substance Use Disorders	20
Prevalence and Penetrance of Rare Pathogenic Variants in Neurodevelopmental Psychiatric Genes in a Health Care System Population	20
Understanding the Efficacy and Mechanism of Action of a Dextromethorphan-Bupropion Combination: Where Does It Fit in the NMDA Versus mu-Opioid Story?	20
Psychotropic Drug–Related Weight Gain and Its Treatment	20
Does Xanomeline/Trospium Have Unique Benefits for Cognitive Impairment Associated With Schizophrenia? Response to Tandon	20
Perinatal Mental Health: Advances and Opportunities	20
Healing, Harms, and Humility: Expanding the Scope of Psychedelic-Assisted Psychotherapy Research	20
Neglect of Adverse Effects in Treatment Guidelines for Depression	19
Recapitulation of Perturbed Striatal Gene Expression Dynamics of Donors’ Brains With Ventral Forebrain Organoids Derived From the Same Individuals With Schizophrenia	19
Highlights From the Residents’ Journal: September 2023	19
Late-Life Depression, Antidepressant Treatment, and Cognition: The Short Haul and the Long Haul	19
Pathogenic Variants and Ascertainment: Neuropsychiatric Disease Risk in a Health System Cohort	19
Antidepressants and Bipolar Disorder: The Plot Thickens	19
Focusing on Substance Use Disorders, Opioids, and Craving	18
Estimating Multimodal Structural Brain Variability in Schizophrenia Spectrum Disorders: A Worldwide ENIGMA Study	18
Varenicline as a First-Line Treatment for Individuals With Current Major Depressive Disorder Who Smoke Cigarettes	18
Effects of County-Level Opioid Dispensing Rates on Individual-Level Patterns of Prescription Opioid and Heroin Consumption: Evidence From National U.S. Data	18
An Insula-Enriched Regulator of Retinoic Acid Marks a New Intersection in the Neural Circuitry of Mouse Social Behavior	18
Putting Genetics to Work in the Psychiatric Clinic	18
Improved Response Inhibition Through Cognition-Guided EEG Neurofeedback in Men With Methamphetamine Use Disorder	18
Neuropsychiatric Symptoms of Subacute and Chronic Long COVID	17
The Devastating Clinical Consequences of Child Abuse and Neglect: Increased Disease Vulnerability and Poor Treatment Response in Mood Disorders	17
Clozapine’s High Incidence of Ileus and Pneumonia Demand Better Clinical Strategies—How Do We Get There?	17

Increased Inflammation in Depression: A Little in All, or a Lot in a Few?	17
Irremediable Psychiatric Suffering, a Potential Indication for Psilocybin Treatment	17
Intermittent Theta Burst Stimulation With Adjunctive D-Cycloserine for Obsessive-Compulsive Disorder: A Randomized Clinical Trial	17
Don’t Throw the Baby Out With the Bathwater: A Need for Nuanced Practice and Additional Research on Telehealth Management of ADHD	17
Polygenic Risk Scores and Genetics in Psychiatry	17
Impact of COVID-19 Telehealth Policy Changes on Buprenorphine Treatment for Opioid Use Disorder	17
Muscarinic Acetylcholine Receptor Agonists as Novel Treatments for Schizophrenia	16
MORE Is Less Pain and Less Opioid Misuse: A Mindful Remedy	16
Highlights From the Residents’ Journal: June 2025	16
Beyond the Landmarks: Where to Next With Biomarkers of Autism?	16
Reports to the Membership	16
Intergenerational Effects of the Fast Track Intervention on Next-Generation Child Outcomes: A Preregistered Randomized Clinical Trial	16
Clozapine, Long-Acting Injectables (and Polypharmacy?) Superior in U.S. and International Registries	16
Disclosure of Editors’ Financial Relationships	16
Association Between Polygenic Risk Scores and Outcome of ECT	16
Affective Disorders, Pharmacogenomics, and Psychiatric Illness-Related Cardiometabolic Problems	16
Xanomeline-Trospium Treatment of Cognitive Impairments of Schizophrenia: Hope for Some, or Hope for All?	15
Treating Depression With Repetitive Transcranial Magnetic Stimulation: A Clinician’s Guide	15
Real-World Evidence on Clinical Outcomes of Commonly Used Antidepressants in Older Adults Initiating Antidepressants for Depression: A Nationwide Cohort Study in Denmark	15
MDMA and MDMA-Assisted Therapy	15
The Intergenerational Impact of Structural Racism and Cumulative Trauma on Depression	15
Psychosis Risk With Prescription Amphetamine	15
An Honest Reckoning With the Amygdala and Mental Illness	15
New Insights Into Major Depression and the Treatment of Bipolar Depression	15
Drug Overdose Prevention: An Exercise in Optimism	14
What is the Link Between Substance-Induced Psychosis and Primary Psychotic Disorders?	14
Seeking New Solutions Addressing Structural Racism, Childhood Trauma, Suicidal Behaviors Across Sexual Orientations, and Postpartum Depression	14
Prospective Associations Between Structural Brain Development and Onset of Depressive Disorder During Adolescence and Emerging Adulthood	14
Disclosure of Editors’ Financial Relationships	14
Mechanism-Focused Randomized Controlled Trials in Youths: Another Step Uphill	13
The Importance and Limitations of Null Findings	13
Adolescent Substance Use and Suicidal Behavior, Internet Overuse, and Shared Genetics Between Problematic Alcohol Use and Other Psychiatric Comorbidities	13
Inequalities in the Incidence of Psychotic Disorders Among Racial and Ethnic Groups	13
Grip Strength as a Marker of Resting-State Network Integrity and Well-Being in Early Psychosis	13
20 Years of Aberrant Salience in Psychosis: What Have We Learned?	13
Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis	12
Prevalence of Suicidal Ideation and Suicide Attempts by Race and Gender in Three Large U.S. Adolescent Cohorts	12
Efficacy and Safety of Lumateperone for Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder: A Phase 3 Randomized Placebo-Controlled Trial	12
Real-Time Assessment of Alcohol Reward, Stimulation, and Negative Affect in Individuals With and Without Alcohol Use Disorder and Depressive Disorders	12
Can Cognitive-Behavioral Therapy Normalize Neural Function in Youths With Pediatric Anxiety Disorders? A Developmental Neuroscience Perspective	12
Correction to Lebois et al.	11
Science Into Policy for the Benefit of Children: The Bucharest Early Intervention Project	11
Perspectives From the National Institutes of Health on Multidimensional Mental Health Disparities Research: A Framework for Advancing the Field	11
Ketamine, the First Associative Anesthetic? Some Considerations on Classifying Psychedelics, Entactogens, and Dissociatives	11
Psychotherapy’s Role for Treatment-Resistant Depression: Reply to Bartova et al.	11
Cortical and Subcortical Brain Alterations in Specific Phobia and Its Animal and Blood-Injection-Injury Subtypes: A Mega-Analysis From the ENIGMA Anxiety Working Group	11
Contraception, Intrauterine Systems, and Depression: Can We Spot the Real Perpetrator?	11
The Psychiatric Bed Crisis in the United States: Understanding the Problem and Moving Toward Solutions	11
Psychopathology in Youth: Treatment, Parenting, and Intergenerational Transmission	11
Real-World Safety of Esketamine Nasal Spray: A Comprehensive Analysis Almost 5 Years After First Approval	11
Predicting Conversion to Psychosis Using Machine Learning: Are We There Yet?	11
Clarifying Confounder Variables and Cross-Sectional Power to Make Causal Conclusions About Race, Adversity, and Brain Differences: Response to Scheeringa	11
Reduced Brain Iron and Striatal Hyperdopaminergia in Schizophrenia: A Quantitative Susceptibility Mapping MRI and PET Study	11
Evaluation of Antipsychotic Reduction Efforts in Patients With Dementia in Veterans Health Administration Nursing Homes	11
Understanding and Addressing Widening Racial Inequalities in Drug Overdose	11
Neuroscientific Advances Supporting New Treatments for Major Depression	11
Correction to Mattes	11
Suicide in Black Females: Response to Mattes	10
Sex-Differential Neuroanatomy in Autism: A Shift Toward Male-Characteristic Brain Structure	10
The Genetic Architecture of Obsessive-Compulsive Disorder: Contribution of Liability to OCD From Alleles Across the Frequency Spectrum	10
Cell Type–Specific Profiles and Developmental Trajectories of Transcriptomes in Primate Prefrontal Layer 3 Pyramidal Neurons: Implications for Schizophrenia	10
Correction to Guintivano et al.	10
Lack of Representation in Psychiatric Research: A Data-Driven Example From Scientific Articles Published in 2019 and 2020 in the American Journal of Psychiatry	10
Using Principles of Trauma-Informed Care to Address Structural Racism in Psychiatric Care	10
Cerebrovascular Disease and Neuropsychiatric Disorders: Translating Findings From the MRI Scanner to the Clinic	10
Psychiatric Genetics and Assessing Telehealth Prescribing of Controlled Substances	10
Five-Year Outcomes of a School-Based Personality-Focused Prevention Program on Adolescent Substance Use Disorder: A Cluster Randomized Trial	10
Polygenic Risk and Social Support in Predicting Depression Under Stress	10
High Burden of Ileus and Pneumonia in Clozapine-Treated Individuals With Schizophrenia: A Finnish 25-Year Follow-Up Register Study	9
Transforming Discoveries About Cortical Microcircuits and Gamma Oscillations Into New Treatments for Cognitive Deficits in Schizophrenia	9
Entactogen Effects of Ketamine: A Reverse-Translational Study	9
Alcohol Use Disorder and Chronic Pain: An Overlooked Epidemic	9
Genetic Underpinnings of the Transition From Alcohol Consumption to Alcohol Use Disorder: Shared and Unique Genetic Architectures in a Cross-Ancestry Sample	9
Infant Visual Brain Development and Inherited Genetic Liability in Autism	9
In Search of Biomarkers to Guide Interventions in Autism Spectrum Disorder: A Systematic Review	9
Charting the Landscape of Genetic Overlap Between Mental Disorders and Related Traits Beyond Genetic Correlation	9
ADHD and ASD: Time to Split or Lump?	8
Correcting Overestimations in Self-Harm Visit Data: Response From Bommersbach and Colleagues	8
Opioid Use Disorder: Pernicious and Persistent	8
More Than Social Stigma Meets the Eye: The Inherent Struggle of Sexual and Gender Identity Development Across the Lifespan	8
Prevalence and Correlates of Cannabis Use and Cannabis Use Disorder Among U.S. Veterans: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC-III)	8
Translational Neuroscience Approaches to Understanding Autism	8
Optimizing the Treatment of Late-Life Depression	8
Structural Racism and the Imperative to Eliminate Mental Health Disparities	8
Telemental Health Care for Children and Adolescents in the United States: Challenges and Opportunities	8
Trends in Prevalence of Cannabis Use Disorder Among U.S. Veterans With and Without Psychiatric Disorders Between 2005 and 2019	8
Association of Cannabis Use–Related Predictor Variables and Self-Reported Psychotic Disorders: U.S. Adults, 2001–2002 and 2012–2013	8
Self-Control Abilities in Specific Types of Problematic Usage of the Internet: Findings From Clinically Validated Samples With Neurocognitive Tasks	7
Correction to Cruceanu et al.	7
Maternal Perinatal Stress Trajectories and Negative Affect and Amygdala Development in Offspring	7
Attention Bias Modification Treatment Versus a Selective Serotonin Reuptake Inhibitor Or Waiting List Control for Social Anxiety Disorder: A Randomized Clinical Trial	7
Identifying and Reducing Bias in Genome-Wide Association Studies of Alcohol-Related Traits	7
Through a Developmental Lens: Emerging Insights to Understand and Treat Pediatric PTSD	7
Adjunctive Cariprazine for the Treatment of Patients With Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study	7
The Influence of Parenting on Callous-Unemotional Traits and the Implications for the Causes and Treatment of Conduct Disorder	7